Prevalence of Helicobacter pylori infection among type 2 diabetes mellitus

Bener, Abdulbari; Ağan, Ahmet Faruk; O. A A. Al-hamaq, Abdulla; Barisik, Cem Cahit; Öztürk, Mustafa; Ömer, Abdulkadir

Prevalence of Helicobacter pylori infection among type 2 diabetes mellitus

Authors

¹ Department of Biostatistics and Medical Informatics, Cerrahpaşa Faculty of Medicine, Istanbul University, Istanbul, Turkey; Department of Evidence for Population Health Unit, Department of Epidemiology and Health Sciences, The University of Manchester, Manchester, UK; Department of Raiology and Pathology, Medipol International School of Medicine, Istanbul Medipol University, Istanbul, Turkey

² Department of Gastroenterology, Medipol International School of Medicine, Istanbul Medipol University, Istanbul, Turkey

³ Qatar Diabetic Associations and Qatar Foundation, Doha, Qatar

⁴ Department of Raiology and Pathology, Medipol International School of Medicine, Istanbul Medipol University, Istanbul, Turkey

⁵ Department of Endocrinology, Medipol International School of Medicine, Istanbul Medipol University, Istanbul, Turkey

Abstract

Background: Several conducted studies have reported a higher and more frequent Helicobacter pylori infection rate in type 2 diabetes mellitus (T2DM). The aim of this study was to investigate the prevalence and its association between H. pylori infection and T2DM. Materials and Methods: A case and control study was conducted based on 529 T2DM patients and 529 control. H. pylori was assessed by Serum anti-H. pylori immunoglobulin G (IgG) and IgA. Furthermore, patients were investigated for fasting blood glucose (FBG) levels, glycosylated hemoglobin (HbA1c), serum cholesterol, and other biochemistry parameters. Results: The findings showed a positive significantly higher antibody titer for H. pylori infection (IgA > 250) in diabetic patients (50.7%) compared to controls (38.2%) (P < 0.001). Similarly, H. pylori infection for IgG > 300 titer was higher in T2DM patients (73.5%) compared to controls 61.8%) (P < 0.001). Further, the mean values were statistically significant diabetes with H. pylori infection for IgG > 300 titer and IgA > 250 titer, regarding Vitamin D, HbA1C (P < 0.001), FBG, calcium, creatinine, total cholesterol, LHDL, triglyceride levels, uric acid, bilirubin, thyroid-stimulating hormone (TSH), and systolic and diastolic blood pressure. The diabetic patients showed higher prevalence rate of symptoms than controls included: hypertension (14.3%), vomiting (15.5%), muscular symptoms (35.2%), bloating/distension (13.2%), abdominal pain (17%), nausea (9.6%), anemia (17%), kidneys (20.8%), chronic bronchitis (14.7%), gastrointestinal (23.8%), and diarrhea (20.4%). Conclusions: The current study revealed that H. pylori infections were significantly higher in diabetic patients compared to controls. Furthermore, T2DM patients infected with H. pylori positive reported a higher prevalence rate of symptoms than H. pylori negative.

Keywords

References

1.	Devrajani BR, Shah SZ, Soomro AA, Devrajani T. Type 2 diabetes mellitus: A risk factor for Helicobacter pylori infection: a hospital based case-control study. Int J Diabetes Dev Ctries 2010;30:22-6.
2.	Vafaeimanesh J, Parham M, Seyyedmajidi M, Bagherzadeh M. Helicobacter pylori Infection and Insulin Resistance in Diabetic and Nondiabetic Population. ScientificWorldJournal. 2014;2014:391250.
3.	Zhou X, Zhang C, Wu J, Zhang G. Association between Helicobacter pylori infection and diabetes mellitus: A meta-analysis of observational studies. Diabetes res Clin Pract 2013;99:200-8.
4.	Agrawal RP, Sharma R, Garg D, Pokharna R, Kochar DK, Kothari RP. role of Helicobacter pylori in causation of diabetic gastropathies and non-gastrointestinal complications in type 2 diabetes. J Indian Med Assoc 2010;108:140-3.
5.	Bener A, Micallef R, Afifi M, Derbala M, Al-Mulla HM, Usmani MA. Association between type 2 diabetes mellitus and Helicobacter pylori infection. Turk J Gastroenterol 2007;18:225-9.
6.	Jafarzadeh A, Rezayati MT, Nemati M. Helicobacter pylori seropositivity in patients with type 2 diabetes mellitus in south-east of Iran. Acta Med Iran 2013;51:892-6.
7.	Marrollo M, Latella G, Melideo D, Storelli E, Iannarelli R, Stornelli P, et al. Increased prevalence of Helicobacter pylori in patients with diabetes mellitus. Dig Liver Dis 2001;33:21-9.
8.	Vafaeimanesh J, Parham M, Bagherzadeh M. Helicobacter pylori infection prevalence: Is it different in diabetics and non-diabetics? Indian J Endocrinol Metab 2015;19:364-8.
9.	Jeon CY, Haan MN, Cheng C, Clayton ER, Mayeda ER, Miller JW,et al. Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care 2012;35:520-5.
10.	Hosseininasab Nodoushan SA, Nabavi A. The interaction of Helicobacter pylori infection and type 2 diabetes mellitus. Adv Biomed Res 2019;8:15.
11.	Fernandini-Paredes GG, Mezones-Holguin E, Vargas-Gonzales R, Pozo-Briceño E, Rodriguez-Morales AJ. In patients with type 2 diabetes mellitus, are glycosylated hemoglobin levels higher for those with Helicobacter pylori infection than those without infection? Clin Infect Dis 2008;47:144-6.
12.	Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 2009;120:1640-5.
13.	Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med 2006;23:469-80.
14.	Andersen LP, Espersen F, Souckova A, Sedlackova M, Soucek A. isolation and preliminary evaluation of a low-molecular-mass antigen preparation for improved detection of Helicobacter pylori immunoglobulin g antibodies. clin diagn lab immunol 1995;2:156-9.
15.	Hafiz QM, Ikram O, Zia MT, Theba FK, Ikram N, Tariq A. Helicobacter pylori infection among type 2 diabetics: A case control study. Int J Res Med Sci 2020;8:1047-50.
16.	Ko GT, Chan FK, Chan WB, Sung JJ, Tsoi CL, To KF, et al. Helicobacter pylori infection in chinese subjects with type 2 diabetes. Endocr Res 2001;27:171-7.
17.	Ebule IA, Djune FA, Njeambosay BA, Doh GN, Metaghue G. Association of Helicobacter pylori infection and diabetes mellitus type 2 subjects in yaounde cameroon using a panel of serum biomarkers (PGII, HPIGG): A case control study.J Clin Gastroenterol Treat 2017;3:53-8.
18.	Wan Z, Song l, Hu L, Hu M, Lei X, Huang Y, et al. Helicobacter pylori infection is associated with diabetes among chinese adults. J Diabetes Investig 2020;11:199-205.
19.	Cheng KP, Yang YJ, Hung HC, Lin CH, Wu CT, Hung MH,et al. Helicobacter pylori eradication improves glycemic control in type 2 diabetes patients with asymptomatic active Helicobacter pylori infection. J Diabetes Investig 2019;10:1092-101.
20.	Senturk O, Canturk Z, Cetinarslan B, Ercin C, Hulagu S, Canturk NZ. Prevalence and comparisons of five different diagnostic methods for Helicobacter pylori in diabetic patients. Endocr Res 2001;27:179-89.
21.	Quatrini M, Boarino V, Ghidoni A, Baldassarri AR, Bianchi PA, Bardella MT. Helicobacter pylori prevalence in patients with diabetes and its relationship to dyspeptic symptoms. J Clin Gastroenterol 2001;32:215-7.
22.	So WY, Tong PC, Ko GT, Ma RC, Ozaki R, Kong AP, et al. Low plasma adiponectin level, white blood cell count and Helicobacter pylori titre independently predict abnormal pancreatic beta-cell function. Diabetes Res Clin Pract 2009;86:89-95.

Advanced Biomedical Research